
The MHRA has shut down an unlicensed Cambridgeshire plant that was producing a potentially dangerous drug to be sold online. …

The UK Bennet Building bioscience laboratory doors have been opened during a ceremony at the Babraham Research Campus in Cambridge …

The European Commission has approved AstraZeneca’s Lynparza for the treatment of advanced BRCA-mutated ovarian cancer. Lynparza (olaparib) has been approved …

Cancer Research UK (CRUK) scientists are to be given access to drug discovery facilities at AstraZeneca’s Cambridge site as part …
UK biotech Horizon Discovery has formed a new Scientific Advisory Board (SAB) for its diagnostics arm to recommend better cancer …

AstraZeneca along with its biologics R&D arm MedImmune are to enter into four new collaborations with the University of Cambridge. …

AstraZeneca’s biologics arm MedImmune has joined forces with Cancer Research UK to establish a new research laboratory in Cambridge, UK. …

AstraZeneca’s new international HQ on the Cambridge Biomedical Campus (CBC), due to open in two years’ time, will feature an …

Gene analysis specialist Illumina has been chosen to deliver a project to sequence 100,000 whole genomes from NHS patients by …

Pfizer has open a new 280,000 sq.ft. R&D hub in Cambridge, Massachusetts which also serves to bring together 1,000 of …
Imperial College London is to build a pioneering biomedical engineering centre that will cement London and the south east’s reputation …

The UK’s Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) and AstraZeneca will join forces to help discover new …

AstraZeneca and the Medical Research Council have entered into a ‘ground-breaking’ collaboration aimed at better understanding the mechanisms of human …

Half a dozen more bioscience companies are to become tenants at the Alderley Park BioHub in Cheshire, filling some of …

Contract research organisation SYNthesis med chem has announced that it has joined the bio-medical cluster by opening a new facility …